Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: Routine excision is not necessary

Modern Pathology

Volumn 21, Issue 10, 2008, Pages 1208-1216

  Hwang, Helena ^a   Barke, Lora D ^b   Mendelson, Ellen B ^c   Susnik, Barbara ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Radiology Imaging Associates   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Atypical lobular hyperplasia; Core biopsy; Lobular carcinoma in situ; Lobular neoplasia; Upgrade

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST DUCT; BREAST HYPERPLASIA; CANCER DIAGNOSIS; CANCER SURGERY; CARCINOMA IN SITU; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; MORPHOLOGY; PREDICTION; PRIORITY JOURNAL; TISSUE NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 52549108448     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.134     Document Type: Article

References (38)

1. Tavassoli FA. Pathology of the Breast, 2nd edn. McGraw-Hill Professional: New York, 1999, pp 373-400.
2. Mastracci TL, Boulos FI, Andrulis IL, et al. Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer. Breast Cancer Res 2007;9:215.
3. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001;115:85-98.
4. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404-411.
5. Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997;76:1131-1133.
6. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002;15:1044-1050.
7. Rosen PP. Rosen's Breast Pathology, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 209-222.
8. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 2000;436:421-430.
9. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 2006;30:1445-1453.
10. Lakhani SR. In-situ lobular neoplasia: time for an awakening. Lancet 2003;361:96.
11. Jacobs TW, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001;25:229-236.
12. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005;207:1-13.
13. Nemoto T, Castillo N, Tsukada Y, , et al., Bauer RL Lobular carcinoma in situ with microinvasion. J Surg Oncol 1998;67:41-46.
14. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002;440:134-138.
15. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624.
16. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-2271.
17. Sanders ME, Schuyler PA, Dupont WD, et al. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005;103:2481-2484.
18. Cohen MA. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 2004;231:617-621.
19. Levine P, Simsir A, Cangiarella J. Management issues in breast lesions diagnosed by fine-needle aspiration and percutaneous core breast biopsy. Am J Clin Pathol 2006;125(Suppl):S124-S134.
20. Bowman K, Munoz A, Mahvi DM, et al. Lobular neoplasia diagnosed at core biopsy does not mandate surgical excision. J Surg Res 2007;142:275-280.
21. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 2001;176:1255-1259.
22. Arpino G, Allred DC, Mohsin SK, et al. Lobular neoplasia on core-needle biopsy - clinical significance. Cancer 2004;101:242-250.
23. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001;218:503-509.
24. Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med 2008;132:979-983.
25. Crisi GM, Mandavilli S, Cronin E, et al. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003;27:325-333.
26. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005;29:534-543.
27. Esserman LE, Lamea L, Tanev S, et al. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J 2007;13:55-61.
28. Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813-819.
29. Karabakhtsian RG, Johnson R, Sumkin J, et al. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol 2007;31:717-723.
30. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 1999;173:291-299.
31. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereo-tactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol 2006;187:949-954.
32. Margenthaler JA, Duke D, Monsees BS, et al. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg 2006;192:534-537.
33. Menon S, Porter GJ, Evans AJ, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch 2008;452:473-479.
34. Middleton LP, Grant S, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 2003;16:120-129.
35. Nagi CS, O'Donnell JE, Tismenetsky M, et al. Lobular neoplasia on core needle biopsy does not require excision. Cancer 2008;112:2152-2158.
36. Renshaw AA, Derhagopian RP, Martinez P, et al. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol 2006;126:310-313.
37. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002;126:697-701.
38. Yeh IT, Dimitrov D, Otto P, et al. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003;127:49-54.